(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRIASTEK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TRIASTEK

ST13

US500000090510903

Class

5, 42

Filing

90510903

Registration

6842056

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

12/29/2023

Trademark type

Word

Nice classes

5, 42

Filing date

02/04/2021

Registration date

09/13/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

09/13/2022

Last transaction

12/29/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

01/18/2021

First use in commerce

01/18/2021

Drawing code

4

Owner type

03

Owner location

Nanjing, Jiangsu, CN

Examiner

VERHOSEK, WILLIAM

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Triastek, Inc.

Representatives

Joyce Liou MORRISON & FOERSTER LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

(Based on 44(e)) Pharmaceutical preparations for the treatment of autoimmunecardiovascularcentral nervous systemendocrinegastrointestinalgeneticimmunologicalinfectiousinflammatorymenopausalmetabolicmusculoskeletalneurodegenerativeneurologicalneuromuscularophthalmologicalpsychiatricrespiratoryurogenitalurological and viral diseases and disorders

Class 42

(Based on Use in Commerce) Pharmaceutical research and development; research and development of technology in the field of pharmaceutical formulationdesigncreation; development of new technology for others in the field of pharmaceuticals; development of pharmaceutical formulations and drug delivery systems

Publications

History of USPTO decisions and trademark events.

26 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

12/29/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/29/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/29/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/29/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

09/13/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

09/13/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/28/2022

PUBO

PUBLISHED FOR OPPOSITION

06/28/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/08/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/24/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/14/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/13/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/13/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/01/2022

GNRT

NON-FINAL ACTION E-MAILED

03/01/2022

CNRT

NON-FINAL ACTION WRITTEN

03/01/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/23/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/23/2022

ALIE

ASSIGNED TO LIE

02/22/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/16/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/30/2021

GNRT

NON-FINAL ACTION E-MAILED

08/30/2021

CNRT

NON-FINAL ACTION WRITTEN

08/30/2021

DOCK

ASSIGNED TO EXAMINER

08/26/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/10/2021

NWAP

NEW APPLICATION ENTERED

02/08/2021

Continuous trademark protection

Get notified about every new filing that threatens TRIASTEK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.